Follow
Zhilong Jia
Zhilong Jia
Chinese PLA General Hospital
Verified email at plagh.org - Homepage
Title
Cited by
Cited by
Year
Heightened innate immune responses in the respiratory tract of COVID-19 patients
Z Zhou, L Ren, L Zhang, J Zhong, Y Xiao, Z Jia, L Guo, J Yang, C Wang, ...
Cell host & microbe 27 (6), 883-890. e2, 2020
9352020
Health and population effects of rare gene knockouts in adult humans with related parents
VM Narasimhan, KA Hunt, D Mason, CL Baker, KJ Karczewski, ...
Science 352 (6284), 474-477, 2016
3172016
High Expression of CPT1A Predicts Adverse Outcomes: A Potential Therapeutic Target for Acute Myeloid Leukemia
J Shi, H Fu, Z Jia, K He, L Fu, W Wang
EBioMedicine 14, 55-64, 2016
842016
Fusobacterium nucleatum facilitates apoptosis, ROS generation, and inflammatory cytokine production by activating AKT/MAPK and NF-κB signaling pathways in human gingival …
W Kang, Z Jia, D Tang, Z Zhang, H Gao, K He, Q Feng
Oxidative medicine and cellular longevity 2019, 2019
702019
Cogena, a novel tool for co-expressed gene-set enrichment analysis, applied to drug repositioning and drug mode of action discovery
Z Jia, Y Liu, N Guan, X Bo, Z Luo, MR Barnes
BMC genomics 17 (1), 1-11, 2016
622016
The active lung microbiota landscape of COVID-19 patients through the metatranscriptome data analysis
Y Han, Z Jia, J Shi, W Wang, K He
BioImpacts: BI 12 (2), 139, 2022
592022
Impacts of the plateau environment on the gut microbiota and blood clinical indexes in han and tibetan individuals
Z Jia, X Zhao, X Liu, L Zhao, Q Jia, J Shi, X Xu, L Hao, Z Xu, Q Zhong, ...
Msystems 5 (1), e00660-19, 2020
442020
Semi-supervised projective non-negative matrix factorization for cancer classification
X Zhang, N Guan, Z Jia, X Qiu, Z Luo
PloS one 10 (9), e0138814, 2015
332015
Gene ranking of RNA-seq data via discriminant non-negative matrix factorization
Z Jia, X Zhang, N Guan, X Bo, MR Barnes, Z Luo
PloS one 10 (9), e0137782, 2015
332015
Transcriptome-based drug repositioning for coronavirus disease 2019 (COVID-19)
Z Jia, X Song, J Shi, W Wang, K He
Pathogens and Disease 78 (4), ftaa036, 2020
272020
The biological impact of blood pressure-associated genetic variants in the natriuretic peptide receptor C gene on human vascular smooth muscle
M Ren, FL Ng, HR Warren, K Witkowska, M Baron, Z Jia, C Cabrera, ...
Human molecular genetics 27 (1), 199-210, 2018
242018
Transcriptional landscape in rat intestines under hypobaric hypoxia
L Tian, Z Jia, Z Xu, J Shi, XJ Zhao, K He
PeerJ 9, e11823, 2021
112021
Transcriptional profiling in the livers of rats after hypobaric hypoxia exposure
Z Xu, Z Jia, J Shi, Z Zhang, X Gao, Q Jia, B Liu, J Liu, C Liu, X Zhao, K He
PeerJ 7, e6499, 2019
102019
Time-course transcriptome analysis for drug repositioning in fusobacterium nucleatum-infected human gingival fibroblasts
W Kang, Z Jia, D Tang, X Zhao, J Shi, Q Jia, K He, Q Feng
Frontiers in cell and developmental biology, 204, 2019
92019
A genetically synthetic protein-based cationic polymer for siRNA delivery
Y Liu, Z Jia, L Li, F Chen
Medical hypotheses 76 (2), 239-240, 2011
72011
Proteomic and clinical biomarkers for acute mountain sickness in a longitudinal cohort
J Yang, Z Jia, X Song, J Shi, X Wang, X Zhao, K He
Communications Biology 5 (1), 1-14, 2022
62022
HFIP: an integrated multi-omics data and knowledge platform for the precision medicine of heart failure
J Wu, M Zhao, T Li, J Sun, Q Chen, C Yin, Z Jia, C Zhao, G Lin, Y Ni, G Xie, ...
Database 2021, baab076, 2021
42021
Gene Signature-Based Drug Repositioning
Z Jia, X Song, J Shi, W Wang, K He
Drug Repurposing-Molecular Aspects and Therapeutic Applications, 2021
22021
Structural variant selection for high-altitude adaptation using single-molecule long-read sequencing
J Shi, Z Jia, X Zhao, J Sun, F Liang, M Park, C Zhao, X Wang, Q Chen, ...
bioRxiv, 2021
22021
Proteomic and clinical biomarkers for acute mountain sickness diagnosis, prognosis, protection, and pathogenesis in a longitudinal cohort
J Yang, Z Jia, X Song, J Shi, X Zhao, K He
medRxiv, 2021
2021
The system can't perform the operation now. Try again later.
Articles 1–20